Drug that targets key mutation found to shrink some tumors

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with several institutions in the U.S. and Australia (and sponsored by pharmaceutical company Amgen Research) has

Updated on: March 08,2024 18

Drug that targets key mutation found to shrink some tumors

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with several institutions in the U.S. and Australia (and sponsored by pharmaceutical company Amgen Research) has

Updated on:March 08,2024 18

Effect of religiosity/spirituality on ovarian cancer diagnosis in African American women

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAn examination of data from a multi-center case-control study of ovarian cancer in African American women found that women who re

Updated on: April 01,2024 16

Effect of religiosity/spirituality on ovarian cancer diagnosis in African American women

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAn examination of data from a multi-center case-control study of ovarian cancer in African American women found that women who re

Updated on:April 01,2024 16

Moderate delays safe in treating colon cancer

by Paul Mayne,University of Western OntarioSchulich School of Medicine & Dentistry medical resident Dr. Kerollos Wanis, left, assists Drs. David Bottoni and Robert Black with a cancer-resect

Updated on: April 09,2024 20

Moderate delays safe in treating colon cancer

by Paul Mayne,University of Western OntarioSchulich School of Medicine & Dentistry medical resident Dr. Kerollos Wanis, left, assists Drs. David Bottoni and Robert Black with a cancer-resect

Updated on:April 09,2024 20

A smart watch for lymphoedema management

by Astrid Tomczak,ETH ZurichThe Dicronis entrepreneurs Laura Jabinet, Jovan Jancev and Patrizia Marschalkova (from left). Credit: ETH Zürich / Florian BachmannAbout ten percent of all cancer pat

Updated on: May 09,2024 4

A smart watch for lymphoedema management

by Astrid Tomczak,ETH ZurichThe Dicronis entrepreneurs Laura Jabinet, Jovan Jancev and Patrizia Marschalkova (from left). Credit: ETH Zürich / Florian BachmannAbout ten percent of all cancer pat

Updated on:May 09,2024 4

Selinexor for multiple myeloma receives accelerated FDA approval

by H. Lee Moffitt Cancer Center & Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-in-class d

Updated on: May 09,2024 4

Selinexor for multiple myeloma receives accelerated FDA approval

by H. Lee Moffitt Cancer Center & Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-in-class d

Updated on:May 09,2024 4

Researcher looks for ways to detect deadly ovarian cancer before it develops

by Denise Heady,University of California, Los AngelesDr. Beth Karlan. Credit: Milo Mitchell/UCLAOut of the 22,240 women in the United States who are diagnosed with ovarian cancer every year, onl

Updated on: June 04,2024 4

Researcher looks for ways to detect deadly ovarian cancer before it develops

by Denise Heady,University of California, Los AngelesDr. Beth Karlan. Credit: Milo Mitchell/UCLAOut of the 22,240 women in the United States who are diagnosed with ovarian cancer every year, onl

Updated on:June 04,2024 4

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on: January 29,2024 18

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Updated on:January 29,2024 18

A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma

by First Hospital of Jilin UniversityVisual Abstract. Credit: Wei-Yue Chen, Jian-Song Ji, Tian Yang, et al.Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fou

Updated on: February 20,2024 20

A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma

by First Hospital of Jilin UniversityVisual Abstract. Credit: Wei-Yue Chen, Jian-Song Ji, Tian Yang, et al.Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fou

Updated on:February 20,2024 20

Experts explore the underlying biology of cancer and potential therapeutic strategies

by Beijing Zhongke Journal Publising Co.ABBS: a special issue focused on mechanism-based studies. Credit: Beijing Zhongke Journal Publising Co. Ltd.Cancer's global impact is severe, affecting mill

Updated on: January 22,2024 19

Experts explore the underlying biology of cancer and potential therapeutic strategies

by Beijing Zhongke Journal Publising Co.ABBS: a special issue focused on mechanism-based studies. Credit: Beijing Zhongke Journal Publising Co. Ltd.Cancer's global impact is severe, affecting mill

Updated on:January 22,2024 19

Access to genomic medicine illustrates precision medicine's delicate future

byOsaka UniversityTest Availability of Multigene Panel Tests in Japan and SwitzerlandCC BY, Nakasato K, Manz C and Kato K (2024) Access, autonomy, and affordability: ethical and human rights iss

Updated on: April 28,2024 0

Access to genomic medicine illustrates precision medicine's delicate future

byOsaka UniversityTest Availability of Multigene Panel Tests in Japan and SwitzerlandCC BY, Nakasato K, Manz C and Kato K (2024) Access, autonomy, and affordability: ethical and human rights iss

Updated on:April 28,2024 0

Experts advise against routine testing for prostate cancer

by British Medical JournalMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Routine testing for prostate cancer is n

Updated on: April 07,2024 20

Experts advise against routine testing for prostate cancer

by British Medical JournalMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Routine testing for prostate cancer is n

Updated on:April 07,2024 20

Study suggests chromosomal errors may hinder some aggressive tumors

by Julie Vera,Mayo ClinicGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.100937Chromosomal errors are a hallmark of cancer cells. Defects in the geno

Updated on: January 22,2024 14

Study suggests chromosomal errors may hinder some aggressive tumors

by Julie Vera,Mayo ClinicGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.100937Chromosomal errors are a hallmark of cancer cells. Defects in the geno

Updated on:January 22,2024 14